Key points are not available for this paper at this time.
High-throughput sequencing can detect minimal residual disease comparable to multiparametric flow cytometry in T-ALL patients.
Wu et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: